USPTO serial 78702351
SGX PHARMACEUTICALS
Reviewed by CopyMark Law Group
Reg. 3529111Status 710
- Filing date
- Status date
- Registration date
- Nov 4, 2008
- Examiner
- CARRUTHERS, SUE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with SGX PHARMACEUTICALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
SAN DIEGO, CA
SAN DIEGO, CA
SAN DIEGO, CA
San Diego, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kent M. Walker, Esq.
Kent M. Walker, Esq. Cooley Godward Kronish LLP4401 Eastgate MallSan Diego, CA 92121-1909UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used for drug discovery, drug design, drug development, structural biology, scientific analysis, kinase inhibition, or biotechnology; chemical compounds and chemical formulations used for drug discovery, drug design, drug development, structural biology, scientific analysis, kinase inhibition, or biotechnology; proteins and protein crystals used for crystallization, drug discovery, drug design, drug development, structural biology, structure determination, scientific analysis or research, or biotechnology; chemicals and chemical preparations used for design, manufacture or development of pharmaceuticals, or pharmaceutical preparations | SECTION 8 - CANCELLED | Aug 30, 2005 |
| 005 | Pharmaceuticals and pharmaceutical preparations used for kinase inhibition or for treating cancer, viral infections, tumors, hematological or oncological disorders, inflammatory disorders, infectious diseases, immune system disorders, allergic disorders, cardiovascular disorders, pulmonary disorders, gastrointestinal disorders, hepatic and biliary disorders, nutritional and metabolic disorders, endocrine disorders, gynecological disorders, obstetric conditions, musculoskeletal and connective tissue disorders, neurological disorders, psychiatric disorders, genitourinary disorders, pediatric conditions, otolaryngological disorders, ophthalmologic disorders, dermatological disorders, dental and oral disorders, disorders due to physical agents, poisoning, venomous bites or stings, or human disease; chemicals and chemical formulations for medical use or for kinase inhibition or for treating human disease, hematological or oncological disorders, or inflammatory disorders | SECTION 8 - CANCELLED | Aug 30, 2005 |
| 009 | Computer software for use in drug discovery, pharmaceutical research, or biotechnology research; computer software for chemical analysis and identification, design, or modification of chemical entities; computer software for protein structure or protein crystal analysis; computer software for coordinated chemical and protein structure analysis | SECTION 8 - CANCELLED | Aug 30, 2005 |
| 042 | Pharmaceutical research, drug discovery, and drug development services; chemical structure analysis or design; identification, design, or modification of chemical entities; protein structure, protein crystal, or protein co-crystal analysis; biotechnology research; bioinformatics research; scientific analysis | SECTION 8 - CANCELLED | Aug 30, 2005 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SGX PHARMACEUTICALS, INC.
- Other trademarks owned by SGX PHARMACEUTICALS, INC.
- Other trademarks owned by SGX PHARMACEUTICALS, INC.
- Other trademarks owned by Structural GenomiX, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named SGX PHARMACEUTICALS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 5, 2015 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Nov 4, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 30, 2008 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Sep 30, 2008 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Sep 15, 2008 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Sep 15, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 15, 2008 | ALIE | ASSIGNED TO LIE | — |
| Sep 11, 2008 | PAPER RECEIVED | — | |
| Mar 10, 2008 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 10, 2008 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 10, 2008 | CNFR | SU - FINAL REFUSAL - WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 25, 2008 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 25, 2008 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 17, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 17, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 17, 2008 | ALIE | ASSIGNED TO LIE | — |
| Jan 16, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 26, 2007 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 26, 2007 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 26, 2007 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 4, 2007 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 4, 2007 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 24, 2007 | IUAF | USE AMENDMENT FILED | — |
| Sep 24, 2007 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 24, 2007 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 24, 2007 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 27, 2007 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 2, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 13, 2006 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 13, 2006 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 9, 2006 | ALIE | ASSIGNED TO LIE | — |
| Nov 3, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 3, 2006 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Nov 2, 2006 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 2, 2006 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 4, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 25, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 21, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 21, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 21, 2006 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 20, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 6, 2005 | NWAP | NEW APPLICATION ENTERED | — |